Bitte wählen Sie Ihren Standort und einen Sektor aus
Materials, chemicals & mining
HuvePharma
Fermentation specialist
Acquired Investment Interest in Seller's Business
Fermentalg
Develops and produces active ingredients extracted from microalgae
Advised on Recapitalization of Company
Advised on the €12.8m capital increase completed by Fermentalg
Fermentalg successfully completed a €12.8 million capital increase designed to further its 2024-2026 strategic plan and consolidate its position as the European leader in sustainable solutions based on marine microalgae biotechnology. The HuvePharma group, European leader in precision fermentation in the animal and human health sectors, and a new industrial partner of Fermentalg since December 2023, invested €7.5 million, becoming a reference shareholder.
An expert in the research and bioindustrial exploitation of microalgae, Fermentalg aims to offer sustainable solutions and innovative products that contribute to the development of healthy, natural and high-performance products. It develops, produces and markets sustainable solutions and active ingredients derived from microalgae, for nutrition, health and the environment.
DegroofPetercam – IMAP France acted as financial adviser to Fermentalg, characterizing the company's financial needs, seeking potential financial and strategic partners, and structuring a market transaction with French banks for the execution of the Private Placement.
Vielen Dank für Ihr Interesse an IMAP. Bitte verwenden Sie das folgende Formular, um uns mehr über Ihre aktuelle Situation zu schildern, sodass sich der richtige Berater so schnell wie möglich bei Ihnen meldet.